Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does RUXOLITINIB Cause Blood triglycerides increased? 96 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 96 reports of Blood triglycerides increased have been filed in association with RUXOLITINIB (OPZELURA). This represents 0.1% of all adverse event reports for RUXOLITINIB.

96
Reports of Blood triglycerides increased with RUXOLITINIB
0.1%
of all RUXOLITINIB reports
11
Deaths
27
Hospitalizations

How Dangerous Is Blood triglycerides increased From RUXOLITINIB?

Of the 96 reports, 11 (11.5%) resulted in death, 27 (28.1%) required hospitalization, and 8 (8.3%) were considered life-threatening.

Is Blood triglycerides increased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for RUXOLITINIB. However, 96 reports have been filed with the FAERS database.

What Other Side Effects Does RUXOLITINIB Cause?

Off label use (12,492) Death (6,561) Fatigue (5,663) Anaemia (3,593) Haemoglobin decreased (3,297) Platelet count decreased (3,028) Diarrhoea (2,531) Asthenia (2,529) Dizziness (2,398) Pneumonia (2,343)

What Other Drugs Cause Blood triglycerides increased?

ISOTRETINOIN (927) EVOLOCUMAB (551) ADALIMUMAB (289) ROSUVASTATIN (287) ATORVASTATIN (228) CLOZAPINE (219) OLANZAPINE (219) EVEROLIMUS (215) ICOSAPENT ETHYL (207) METFORMIN (199)

Which RUXOLITINIB Alternatives Have Lower Blood triglycerides increased Risk?

RUXOLITINIB vs SABRIL RUXOLITINIB vs SACCHAROMYCES CEREVISIAE RUXOLITINIB vs SACITUZUMAB GOVITECAN RUXOLITINIB vs SACITUZUMAB GOVITECAN-HZIY RUXOLITINIB vs SACROSIDASE

Related Pages

RUXOLITINIB Full Profile All Blood triglycerides increased Reports All Drugs Causing Blood triglycerides increased RUXOLITINIB Demographics